nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—Matrix Metalloproteinases—TIMP4—abdominal aortic aneurysm	0.0842	0.0842	CbGpPWpGaD
Clenbuterol—NGF—NF-kB is activated and signals survival—NFKB1—abdominal aortic aneurysm	0.0404	0.0404	CbGpPWpGaD
Clenbuterol—NGF—p75NTR signals via NF-kB—NFKB1—abdominal aortic aneurysm	0.0342	0.0342	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—LRP1—abdominal aortic aneurysm	0.0307	0.0307	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.0278	0.0278	CbGpPWpGaD
Clenbuterol—NGF—p75(NTR)-mediated signaling—MMP3—abdominal aortic aneurysm	0.0231	0.0231	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—NCF1—abdominal aortic aneurysm	0.0179	0.0179	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.0164	0.0164	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—LDLR—abdominal aortic aneurysm	0.016	0.016	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—LRP1—abdominal aortic aneurysm	0.0149	0.0149	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 signaling events—AGTR1—abdominal aortic aneurysm	0.0134	0.0134	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—LDLR—abdominal aortic aneurysm	0.013	0.013	CbGpPWpGaD
Clenbuterol—TNF—Overview of nanoparticle effects—PTGS2—abdominal aortic aneurysm	0.0125	0.0125	CbGpPWpGaD
Clenbuterol—TNF—Monoamine Transport—AGT—abdominal aortic aneurysm	0.0123	0.0123	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—AGTR1—abdominal aortic aneurysm	0.0122	0.0122	CbGpPWpGaD
Clenbuterol—ADRB1—Melatonin metabolism and effects—APOE—abdominal aortic aneurysm	0.011	0.011	CbGpPWpGaD
Clenbuterol—ADRB2—Arf6 trafficking events—AGTR1—abdominal aortic aneurysm	0.0106	0.0106	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—LDLR—abdominal aortic aneurysm	0.0103	0.0103	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.0101	0.0101	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—SOD2—abdominal aortic aneurysm	0.0101	0.0101	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—NOS2—abdominal aortic aneurysm	0.00998	0.00998	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—MMP2—abdominal aortic aneurysm	0.00962	0.00962	CbGpPWpGaD
Clenbuterol—TNF—Canonical NF-kappaB pathway—NFKB1—abdominal aortic aneurysm	0.00932	0.00932	CbGpPWpGaD
Clenbuterol—TNF—EBV LMP1 signaling—NFKB1—abdominal aortic aneurysm	0.00932	0.00932	CbGpPWpGaD
Clenbuterol—NGF—p75 NTR receptor-mediated signalling—NFKB1—abdominal aortic aneurysm	0.00926	0.00926	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—CCL2—abdominal aortic aneurysm	0.009	0.009	CbGpPWpGaD
Clenbuterol—CYP1A1—Oxidative Stress—SOD2—abdominal aortic aneurysm	0.00848	0.00848	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—AGTR1—abdominal aortic aneurysm	0.00847	0.00847	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—APOE—abdominal aortic aneurysm	0.00829	0.00829	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—SOD2—abdominal aortic aneurysm	0.00823	0.00823	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—CCL2—abdominal aortic aneurysm	0.00813	0.00813	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—abdominal aortic aneurysm	0.00803	0.00803	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.00767	0.00767	CbGpPWpGaD
Clenbuterol—TNF—Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00761	0.00761	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—MMP9—abdominal aortic aneurysm	0.00723	0.00723	CbGpPWpGaD
Clenbuterol—TNF—amb2 Integrin signaling—NFKB1—abdominal aortic aneurysm	0.00715	0.00715	CbGpPWpGaD
Clenbuterol—CYP1A1—Melatonin metabolism and effects—APOE—abdominal aortic aneurysm	0.00714	0.00714	CbGpPWpGaD
Clenbuterol—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—NFKB1—abdominal aortic aneurysm	0.00698	0.00698	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—CCL2—abdominal aortic aneurysm	0.00696	0.00696	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—MMP2—abdominal aortic aneurysm	0.00673	0.00673	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.00657	0.00657	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.00653	0.00653	CbGpPWpGaD
Clenbuterol—ADRB1—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	0.00653	0.00653	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—SERPINE1—abdominal aortic aneurysm	0.0065	0.0065	CbGpPWpGaD
Clenbuterol—TNF—IL23-mediated signaling events—NFKB1—abdominal aortic aneurysm	0.00637	0.00637	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—SERPINE1—abdominal aortic aneurysm	0.00621	0.00621	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—PTGS2—abdominal aortic aneurysm	0.00617	0.00617	CbGpPWpGaD
Clenbuterol—NGF—BDNF signaling pathway—NFKB1—abdominal aortic aneurysm	0.0059	0.0059	CbGpPWpGaD
Clenbuterol—TNF—Alzheimers Disease—APOE—abdominal aortic aneurysm	0.00584	0.00584	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—MMP9—abdominal aortic aneurysm	0.00582	0.00582	CbGpPWpGaD
Clenbuterol—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—abdominal aortic aneurysm	0.00577	0.00577	CbGpPWpGaD
Clenbuterol—TNF—TWEAK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00576	0.00576	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—AGT—abdominal aortic aneurysm	0.00567	0.00567	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—CCL2—abdominal aortic aneurysm	0.00567	0.00567	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.00553	0.00553	CbGpPWpGaD
Clenbuterol—TNF—TNF receptor signaling pathway —NFKB1—abdominal aortic aneurysm	0.00535	0.00535	CbGpPWpGaD
Clenbuterol—TNF—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.00535	0.00535	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.00529	0.00529	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00521	0.00521	CbGpPWpGaD
Clenbuterol—TNF—Ceramide signaling pathway—NFKB1—abdominal aortic aneurysm	0.00517	0.00517	CbGpPWpGaD
Clenbuterol—TNF—Angiopoietin receptor Tie2-mediated signaling—NFKB1—abdominal aortic aneurysm	0.00501	0.00501	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.005	0.005	CbGpPWpGaD
Clenbuterol—TNF—Vitamin B12 Metabolism—NFKB1—abdominal aortic aneurysm	0.00493	0.00493	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—abdominal aortic aneurysm	0.00478	0.00478	CbGpPWpGaD
Clenbuterol—TNF—TGF-beta Receptor Signaling—NFKB1—abdominal aortic aneurysm	0.00471	0.00471	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00467	0.00467	CbGpPWpGaD
Clenbuterol—TNF—Cardiac Hypertrophic Response—NFKB1—abdominal aortic aneurysm	0.00464	0.00464	CbGpPWpGaD
Clenbuterol—CYP1A2—Melatonin metabolism and effects—APOE—abdominal aortic aneurysm	0.00456	0.00456	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.00455	0.00455	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.0045	0.0045	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—P2RY12—abdominal aortic aneurysm	0.00445	0.00445	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—CCL2—abdominal aortic aneurysm	0.00434	0.00434	CbGpPWpGaD
Clenbuterol—CYP1A1—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	0.00425	0.00425	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.0042	0.0042	CbGpPWpGaD
Clenbuterol—CYP1A1—Oxidative Stress—NFKB1—abdominal aortic aneurysm	0.00414	0.00414	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—CDKN2A—abdominal aortic aneurysm	0.00407	0.00407	CbGpPWpGaD
Clenbuterol—TNF—Folate Metabolism—NFKB1—abdominal aortic aneurysm	0.00401	0.00401	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—AGT—abdominal aortic aneurysm	0.004	0.004	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.004	0.004	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—NOS2—abdominal aortic aneurysm	0.00395	0.00395	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.0039	0.0039	CbGpPWpGaD
Clenbuterol—TNF—Signaling events mediated by HDAC Class I—NFKB1—abdominal aortic aneurysm	0.00382	0.00382	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.00382	0.00382	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.00367	0.00367	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—CCL2—abdominal aortic aneurysm	0.00356	0.00356	CbGpPWpGaD
Clenbuterol—TNF—Transcriptional regulation of white adipocyte differentiation—NFKB1—abdominal aortic aneurysm	0.00354	0.00354	CbGpPWpGaD
Clenbuterol—NGF—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.00341	0.00341	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—abdominal aortic aneurysm	0.00338	0.00338	CbGpPWpGaD
Clenbuterol—TNF—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—abdominal aortic aneurysm	0.00331	0.00331	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—NFKB1—abdominal aortic aneurysm	0.00331	0.00331	CbGpPWpGaD
Clenbuterol—TNF—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.00318	0.00318	CbGpPWpGaD
Clenbuterol—CYP1A1—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.00317	0.00317	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00314	0.00314	CbGpPWpGaD
Clenbuterol—TNF—Adipogenesis—SERPINE1—abdominal aortic aneurysm	0.00308	0.00308	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00307	0.00307	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00305	0.00305	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.00297	0.00297	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.00294	0.00294	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00293	0.00293	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.00291	0.00291	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—PTGS2—abdominal aortic aneurysm	0.0029	0.0029	CbGpPWpGaD
Clenbuterol—TNF—Toll-like Receptor Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00283	0.00283	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00283	0.00283	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00281	0.00281	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00277	0.00277	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—abdominal aortic aneurysm	0.00271	0.00271	CbGpPWpGaD
Clenbuterol—CYP1A2—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	0.00271	0.00271	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00257	0.00257	CbGpPWpGaD
Clenbuterol—TNF—Spinal Cord Injury—MMP9—abdominal aortic aneurysm	0.00255	0.00255	CbGpPWpGaD
Clenbuterol—CYP1A1—PPARA activates gene expression—AGT—abdominal aortic aneurysm	0.00251	0.00251	CbGpPWpGaD
Clenbuterol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—abdominal aortic aneurysm	0.00246	0.00246	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00238	0.00238	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00237	0.00237	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00232	0.00232	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00232	0.00232	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00222	0.00222	CbGpPWpGaD
Clenbuterol—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—abdominal aortic aneurysm	0.00221	0.00221	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—abdominal aortic aneurysm	0.00216	0.00216	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00214	0.00214	CbGpPWpGaD
Clenbuterol—CYP1A2—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	0.00202	0.00202	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—NFKB1—abdominal aortic aneurysm	0.00201	0.00201	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.00197	0.00197	CbGpPWpGaD
Clenbuterol—TNF—MAPK Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.0019	0.0019	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.00187	0.00187	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00181	0.00181	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00178	0.00178	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00177	0.00177	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00176	0.00176	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00172	0.00172	CbGpPWpGaD
Clenbuterol—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.00171	0.00171	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—abdominal aortic aneurysm	0.00169	0.00169	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00168	0.00168	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00167	0.00167	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00164	0.00164	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00163	0.00163	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00162	0.00162	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00159	0.00159	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00156	0.00156	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00152	0.00152	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00152	0.00152	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00149	0.00149	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00139	0.00139	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00138	0.00138	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00135	0.00135	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.00128	0.00128	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00127	0.00127	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00126	0.00126	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00124	0.00124	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00123	0.00123	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00123	0.00123	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00121	0.00121	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00115	0.00115	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.0011	0.0011	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP2—abdominal aortic aneurysm	0.00108	0.00108	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00105	0.00105	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00103	0.00103	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00102	0.00102	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00102	0.00102	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000999	0.000999	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000966	0.000966	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000963	0.000963	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000942	0.000942	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000928	0.000928	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000923	0.000923	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000907	0.000907	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000906	0.000906	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.0009	0.0009	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000881	0.000881	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000827	0.000827	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000823	0.000823	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000813	0.000813	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MMP9—abdominal aortic aneurysm	0.00081	0.00081	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000809	0.000809	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000801	0.000801	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00074	0.00074	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000732	0.000732	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00073	0.00073	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000719	0.000719	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000714	0.000714	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000703	0.000703	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000682	0.000682	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000674	0.000674	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000668	0.000668	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.00066	0.00066	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000653	0.000653	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AAAS—abdominal aortic aneurysm	0.000651	0.000651	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00065	0.00065	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000639	0.000639	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000637	0.000637	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—LDLR—abdominal aortic aneurysm	0.000568	0.000568	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000548	0.000548	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000538	0.000538	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000536	0.000536	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000535	0.000535	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000526	0.000526	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.0005	0.0005	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000488	0.000488	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000478	0.000478	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000452	0.000452	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.00043	0.00043	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000421	0.000421	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AAAS—abdominal aortic aneurysm	0.000415	0.000415	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000386	0.000386	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000383	0.000383	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000379	0.000379	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000378	0.000378	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000377	0.000377	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00037	0.00037	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LDLR—abdominal aortic aneurysm	0.000362	0.000362	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000318	0.000318	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000311	0.000311	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AGT—abdominal aortic aneurysm	0.0003	0.0003	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000296	0.000296	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOE—abdominal aortic aneurysm	0.000294	0.000294	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00029	0.00029	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000289	0.000289	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000227	0.000227	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000225	0.000225	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000222	0.000222	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.00022	0.00022	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000202	0.000202	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AGT—abdominal aortic aneurysm	0.000191	0.000191	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOE—abdominal aortic aneurysm	0.000188	0.000188	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—abdominal aortic aneurysm	0.000128	0.000128	CbGpPWpGaD
